• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Hypercalcemia as incidental finding--what should be done?].

作者信息

Burckhardt P

机构信息

Département de médecine interne, Service de médecine interne A CHUV, Lausanne.

出版信息

Schweiz Rundsch Med Prax. 1994 Jan 18;83(3):75-8.

PMID:8296134
Abstract

The discovery of a hypercalcemia validated by exclusion of hemoconcentration and follow-up calcium determinations opens the differential diagnosis of a malignancy and of hyperthyroidism whereas drug-induced causes can be recognized easily. A single determination of plasmatic parathyroid hormone (PTH) allows to safely distinguish between PTH-induced or PTH-independent, most often tumor-associated hypercalcemia. In both instances the patient may be free of symptoms particularly the very old one. Therapeutic measures are indicated in both instances: Treatment of malignancy-associated hypercalcemia is clinically effective and treatment of asymptomatic hyperthyroidism is likewise recommended, mainly to preserve bone mass and cerebral performance.

摘要

相似文献

1
[Hypercalcemia as incidental finding--what should be done?].
Schweiz Rundsch Med Prax. 1994 Jan 18;83(3):75-8.
2
[Should the parathyroid function be evaluated in a patient with calcium kidney stones? If so, when and why?].
Nephrologie. 1991;12(2):71-7.
3
[Hypercalcemia is the most common manifestation of hyperparathyroidism].高钙血症是甲状旁腺功能亢进最常见的表现。
Nihon Rinsho. 1995 Apr;53(4):864-9.
4
Hypercalcemic hypocalciuria: a critical differential diagnosis for hyperparathyroidism.高钙血症性低钙尿症:甲状旁腺功能亢进的关键鉴别诊断。
Otolaryngol Clin North Am. 2004 Aug;37(4):887-96, xi. doi: 10.1016/j.otc.2004.02.015.
5
[Hypercalcemia disclosing primary hyperparathyroidism. Diagnostic pitfalls].
Ann Med Interne (Paris). 1989;140(6):538-9.
6
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
7
[Clinical significance of asymptomatic hypercalcemia].无症状性高钙血症的临床意义
Schweiz Med Wochenschr. 1985 May 25;115(21):733-7.
8
[Hypercalcemia: symptom and syndrome].
Internist (Berl). 1985 Jul;26(7):405-10.
9
[Malignant hypercalcemia after treatment of breast cancer].
J Gynecol Obstet Biol Reprod (Paris). 1992;21(7):775-7.
10
Differential diagnosis of hypercalcemia.
N Engl J Med. 1966 Mar 24;274(12):674-7. doi: 10.1056/NEJM196603242741208.